Steven, P.
Faust, C.
Holtick, U.
Scheid, C.
Tahmaz, V.
Stern, M. E.
Gehlsen, U.
Article History
Received: 5 July 2019
Revised: 20 December 2019
Accepted: 30 January 2020
First Online: 10 February 2020
Compliance with ethical standards
:
: CF, UH, CS, VT, and UG have nothing to disclose. MES is chief scientific officer of ImmunEyez LLC and member of the scientific advisory board of Novaliq. PS has received financial support from Novaliq GmbH, Roche, Bausch&Lomb, Ursapharm and honoraria from Santen. The Division of Dry-eye and Ocular GvHD received donations from Novaliq, Ursapharm and Juergen and Monika Ziehm.